English 
Salesforce Japan Co., Ltd. announced the launch of “Life Sciences Cloud for Customer Engagement,” a new AI agent-first solution that revolutionizes how life sciences companies engage with healthcare professionals (HCPs). The solution will be available in the U.S. market on October 11, 2025, and in Japan in late November 2025. Salesforce is expanding its Life Sciences Cloud portfolio with this new module, aiming to solve critical challenges facing the industry.
Increasing physician workloads have led to a 75% increase in information processing per drug product compared to 10 years ago. Yet, only one-third of healthcare professionals feel their needs are being met , with some citing information from pharmaceutical and medical device companies as ” spam.” Amidst increasingly stringent regulations and the pressures of building an R&D pipeline , the Life Sciences Cloud harnesses the digital workforce to reduce information overload, foster meaningful engagement, and close gaps in healthcare.
また、ライフサイエンスクラウドは、営業、マーケティング、メディカルサイエンスリエゾン（MSL）、および臨床開発における機能横断的なコラボレーションを可能にします。Agentforce は、医薬品と医療機器の開発、承認、アクセス、および投与方法を再構築し、最も重要なこと、すなわち医療に集中するための人的資源を確保します。
こちらもお読みください： ランテウスとGEヘルスケア、日本におけるPYLARIFYで提携
でネイティブに構築されています。 セールスフォース‘s single, unified platform, Life Sciences Cloud for Customer Engagement goes beyond traditional CRM to deliver a consumer-grade, conversational user experience and enterprise-grade security and compliance directly within the workflow, empowering sales reps to maximize their limited meeting time with busy healthcare professionals. With voice-to-text notes, compliance checks, podcast-like storytelling, and concise account summaries, on-the-go medical representatives, medical sales representatives, and sales representatives have 24/7 access to critical information, empowering healthcare professionals to deliver the best possible patient care.
ソース PRタイムズ
日本語